June
Rare Disease: No HTA Approval? – No Problem!
From national roadblock to local breakthrough: practical pathways to Rare Disease funding
What happens when HTA approval isn’t achievable? Join market access expert Phil Cox to explore how Rare Disease teams can pivot from national roadblocks to targeted, high-impact NHS funding strategies for the most severely affected patients – even without formal approval.